SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : The Philosophical Porch -- Ignore unavailable to you. Want to Upgrade?


To: chip who wrote (12869)3/27/2022 10:19:57 PM
From: Rarebird2 Recommendations

Recommended By
chip
Cogito Ergo Sum

  Read Replies (2) | Respond to of 26251
 
I have 40% of my portfolio in healthcare. The only medical products stock I am long is BDX, which I am up about 7% since I bought in December. TMO, WAT, A and DHR are all out of my league. They are selling for multiples in the mid to upper 20's. In the case of TMO, there is 10%-15% upside, technically speaking. But I don't go long high multiple stocks and by doing so, I've kept out of trouble this year while my portfolio is up close to 8%.

I am a big fan of BDX. The stock is selling for twenty times next year's earnings, which is slightly rich for me, but I like the chart, upper management and above all, the fundamentals of the company. I have a price target of $310 for this low beta stock, which has held up quite well throughout the volatile times.

I am a value player who is long BDX, DGX, MRK, PFE, AMGN, BMY, JNJ, ABC, CI and HUM in the sector. Some are significant positions.

I am not to impressed with IHI or most medical products stocks. I have strict valuation criterions unless the stock is a dominant player ( or the potential to be one) and massive cash cow. MSFT and GOOG are dominant market players and deserve a premium valuation. Actually, GOOG is selling at a cheaper multiple than the medical product stocks you referred to.

There is massive insider selling in TMO.

My prime concern is with not losing my Ass. If I can focus on that, profits will come naturally.